title: Effect of cyclosporine on immune responses in submaxillary lymph nodes of pituitary-grafted rats.
abstract: This work was undertaken to analyze the interrelationships between prolactin and cyclosporine in affecting immune responsiveness in submaxillary lymph nodes. Male rats received an anterior pituitary graft within breast muscles on day 5, or under the kidney capsule, on day 30 or 60 of life. On day 70 (rats operated on day 5 or 30) or on day 100 (rats operated on day 60) animals were injected with Freund's complete adjuvant and cyclosporine (5 mg/kg for 5 days), and were killed 2 days after immunization. Natural killer (NK) activity in submaxillary lymph node decreased in neonatally pituitary-grafted rats and increased in rats grafted on day 30 or 60, as did lymph node cellularity. Lipopolysaccharide (LPS)- and concanavalin A (ConA)-induced proliferation diminished in lymph nodes of rats grafted on day 30 or 60, respectively. Cyclosporine treatment diminished lymph node cell number and NK activity and increased the proliferative response to ConA. Cyclosporine depressive effect on lymph node cellularity was counteracted by the presence of a pituitary graft, as were the inhibition of NK activity and the stimulatory effect on ConA-induced cell proliferation. In pituitary-grafted rats, cyclosporine decreased submaxillary lymph node LPS-induced proliferation. Cyclosporine decreased the high circulating prolactin levels found in pituitary-grafted rats. The results are compatible with age-dependent, inhibitory and promoting activities of hyperprolactinemia on immune responses in lymph nodes, affected in a complex antagonistic and synergistic way by cyclosporine immunosuppression.
authors.affiliation: Departmento de Bioquímica y Biología Molecular III, Facultad de Medicina, Universidad Complutense, Madrid, España.
authors.forename: A
authors.initials: A
authors.lastname: Arce
authors.forename: P O
authors.initials: PO
authors.lastname: Castrillón
authors.forename: V
authors.initials: V
authors.lastname: Della Maggiore
authors.forename: D P
authors.initials: DP
authors.lastname: Cardinali
authors.forename: A I
authors.initials: AI
authors.lastname: Esquifino
mesh_terms: D000375:Aging / Q000502:physiology; D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D003208:Concanavalin A / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology*; D005620:Freund's Adjuvant / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000502:physiology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008198:Lymph Nodes / Q000166:cytology / Q000187:drug effects* / Q000276:immunology*; D008297:Male; D010902:Pituitary Gland / Q000637:transplantation*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D007166:Immunosuppressive Agents; D008070:Lipopolysaccharides; D003208:Concanavalin A; D016572:Cyclosporine; D005620:Freund's Adjuvant